Search results for "OUTCOME"

showing 10 items of 5148 documents

Open mini-invasive cholecystectomy in high risk elderly. A review of 121 consecutive procedures.

2011

INTRODUCTION: the report describes the features of a low cost, open mini-invasive procedure for cholecystectomy in a sample of 121 consecutive high risk elderly (ASA score 3 to 5). PATIENTS AND METHODS: the surgery is performed through a 3 - 4 cm right subcostal skin incision. An optimal exposition of the operating field was achieved thanks to an innovative three valve retractor. RESULTS: a mean hospital stay of 3,02 days, low complication rate and 2,4% mortality are the results of the described procedure. CONCLUSIONS: in high risk elderly the results are extremely encouraging, particularly in comparison with both laparoscopic and traditional open cholecystectomy. The open minisurgical chol…

Aged 80 and overMaleLaparotomyTime FactorsCost-Benefit AnalysisFrail ElderlyLength of StayMiddle AgedRisk AssessmentRadiographySettore MED/18 - Chirurgia GeneraleTreatment OutcomeCholecystectomy LaparoscopicCholelithiasisRisk FactorsHumansMinimally Invasive Surgical ProceduresCholecystectomyFemaleopen mini-invasive cholecystectomyAgedRetrospective Studies
researchProduct

Loup-assisted technique to create arterio-venous fistulas in elderly. A single centre experience

2019

AIMS: The radio-cephalic arteriovenous fistula (RCAVF) is the first choice treatment in end-stage renal disease patients. In the last few years, the hemodialysis population has shown a high percentage of elderly patients (> 65 year old) with comorbidities, mainly vascular diseases, which may adversely affect their vascular access success. The aim of this study was to evaluate the effectiveness of a loup-assisted technique to create RCAVFs in over 65 patients. PATIENTS AND METHODS: 98 consecutive patients with renal failure were prospectively observed. The patient were divided in relation to their age (> 65 year old; < 65 year old). In both groups, a microsurgical distal RCAVF was c…

Aged 80 and overMalePatient SelectionMiddle AgedArteriovenous Shunt SurgicalTreatment OutcomeRenal DialysisRenal DialysiHumansKidney Failure ChronicFemaleHemodialysiElderly patientAgedRadio-cephalic arteriovenouHuman
researchProduct

Prosthetic joint infection caused by Mycobacterium avium complex.

2019

Aged 80 and overMaleProsthesis-Related Infectionsbiologybusiness.industryProsthetic joint infectionGeneral Medicinebiology.organism_classificationMycobacterium avium ComplexMicrobiologyFatal OutcomePositron-Emission TomographyMedicineHumansMycobacterium avium complexHip ProsthesisbusinessMycobacterium avium-intracellulare InfectionQJM : monthly journal of the Association of Physicians
researchProduct

"Downward steps technique" with CO2 ultrapulsed laser for the treatment of rhinophyma: our protocol.

2013

Abstract BACKGROUND: The rhinophyma is an important soft-tissue hypertrophy of the nose. In literature a wide range of surgical approaches to rhinophyma has been described such as dermoabrasion, scalpel shave, cryosurgery, electrocautery, near total excision with skin grafting, and laser excision. PATIENTS AND METHODS: The authors describe their experience with CO(2) ultrapulsed laser in 14 elderly male patients, using their personal approach, the Downward steps technique. With this technique they removed the pathological hypertrophic tissue using a progressive reduction of the laser power during the treatment. They obtained good results from morphological and aesthetic point of view, in a …

Aged 80 and overMaleSettore MED/19 - Chirurgia PlasticaMiddle AgedRhinoplastyTreatment OutcomeLASER CO2 RHINOPHYMALasers GasRhinophymaHumansLaser TherapyAgedFollow-Up StudiesRetrospective StudiesActa chirurgiae plasticae
researchProduct

Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: An Italian clinical experience

2011

Aims and Background: We investigated the efficacy of docetaxel plus prednisone in Italian patients with metastatic hormone- refractory prostate cancer (mHRPC). Methods: Twenty four patients with mHRPC received docetaxel 75 mg/m2 every 3 weeks plus prednisone 5 mg twice daily for up to six cycles. The primary endpoint was efficacy measured by a reduction in serum prostate specific antigen (PSA) levels and measurable disease. Evaluation of toxicity, quality of life and reduction of pain were secondary endpoints. Results: PSA response was seen in 18 patients (75%). We observed a partial response in 2 patients (8.3%), stable disease in 10 patients (41.7%), and disease progression in 12 patients…

Aged 80 and overMaleTime FactorsAntineoplastic Agents HormonalSettore MED/06 - Oncologia MedicaProstatic NeoplasmsDocetaxelAdenocarcinomaMiddle AgedProstate-Specific AntigenTreatment OutcomeItalyDrug Resistance NeoplasmAntineoplastic Combined Chemotherapy ProtocolsDisease ProgressionHumansPrednisoneTaxoidsAdenocarcinoma Antineoplastic combined chemiotherapy protocols Docetaxel Drug-resistace Neoplasm Prednisone Prostatic neoplasm TaxoidsAgedNeoplasm Staging
researchProduct

Laparoscopic subtotal gastrectomy for the treatment of advanced gastric cancer: a comparison with open procedure at the beginning of the learning cur…

2017

Background: In the last decades, after some initial concern, laparoscopic subtotal gastrectomy (LSG) is gaining popularity also for the treatment of advanced gastric cancer (AGC). The aim of this study is to compare a single surgeon initial experience on LSG and open subtotal gastrectomy in terms of surgical safety and radicality, postoperative recovery and midterm oncological outcomes. Methods: a case control study was conducted matching the first 13 LSG for AGC with 13 open procedures performed by the same surgeon. Operative and pathological data, postoperative parameters and midterm oncological outcomes were analyzed. Results: There was no significant difference in mortality (0%) and mor…

Aged 80 and overMalegastric cancerlaparoscopic gastrectomyOperative TimeRecovery of FunctionMiddle AgedsurvivalSurvival RateTreatment OutcomeGastrectomyStomach NeoplasmslymphadenectomyHumansFemaleLaparoscopyOriginal ArticleLearning CurveAgedRetrospective StudiesActa bio-medica : Atenei Parmensis
researchProduct

Surgical repair of popliteal artery aneurysms remains a safe treatment option in the endovascular era: a 10-year single-center study

2012

Introduction: Endovascular popliteal artery aneurysm repair has emerged recently as a feasible alternative to standard surgical repair. However the evidence from the literature is still limited, with only case reports, case series and one small randomized trial. Currently these data suggest the use of stent-grafts in patients at very high surgical risk. The purpose of this study is to present our surgical experience in popliteal artery aneurysm repair in an era of endovascular philosophy. Materials and Methods: Data from 36 consecutive patients who were admitted to our hospital from January 2000 to April 2010, were analyzed retrospectively. Twenty-six patients underwent surgical treatment t…

Aged 80 and overTime FactorsPopliteal arteryEndovascular ProceduresMiddle AgedAneurysmSettore MED/22 - Chirurgia VascolareAneurysm; Popliteal artery; Open Repair; OutcomeHumansOpen RepairAgedFollow-Up StudiesRetrospective StudiesOutcome
researchProduct

Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results fro…

2022

Abstract Objective To evaluate the efficacy of prescription-grade Crystalline Glucosamine Sulfate (pCGS) as an add-on treatment to conventional therapy, compared to usual therapy alone, in patients with erosive osteoarthritis of the hand (EHOA). Methods This 6-month retrospective case–control study included patients with concomitant knee osteoarthritis and symptomatic EHOA. Participants were stratified into two groups based on whether or not pCGS (1500 mg/day) was added to the conventional therapy (education and training in ergonomic principles, exercise and use on-demand of symptomatic drugs) for hand osteoarthritis. Patients were evaluated at baseline, after 3 and 6 months. Primary outcom…

AgingGlucosamineSymptomatic slow-acting drugs for osteoarthritisPainOsteoarthritis KneePrescription-grade crystalline glucosamine sulfateErosive hand osteoarthritis; Hand osteoarthritis; Pain; Prescription-grade crystalline glucosamine sulfate; Retrospective study; Symptomatic slow-acting drugs for osteoarthritisErosive hand osteoarthritisRetrospective studyPrescriptionsTreatment OutcomeCase-Control StudiesHand osteoarthritisHumansErosive hand osteoarthritis Hand osteoarthritis Pain Prescription-grade crystalline glucosamine sulfate Retrospective study Symptomatic slow-acting drugs for osteoarthritisGeriatrics and GerontologyRetrospective StudiesAging clinical and experimental research
researchProduct

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

2020

Abstract Background In 2016, an expert working group was convened under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and formulated consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia. Aims The objective of the current paper is to provide a 2020 update of the previous recommendations in accordance with the evidence that has become available since our original recommendations. Methods This paper is based on literature reviews performed by members of the ESCEO working group and followed up with face to face meetings organized for the whole group to make amendments and discuss…

AgingSarcopeniaGeriatrics & GerontologyStandardizationDiseaseReviewRecommendationsFace-to-face0302 clinical medicineQUALITY-OF-LIFEGAIT SPEEDClinical trial; Drug registration; Guidelines; Recommendations; Sarcopenia; Treatment; Aged; Humans; Muscle Strength; Osteoarthritis; Osteoporosis; Pharmaceutical Preparations; Sarcopenia030212 general & internal medicineMUSCLE MASSDIETARY-PROTEINClinical trialPhysical limitationsPharmaceutical Preparations/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPatient-reported outcomeGRIP STRENGTHLife Sciences & Biomedicinemedicine.medical_specialtyNUTRITIONAL-STATUSBODY-COMPOSITION030209 endocrinology & metabolismGuidelines03 medical and health sciencesClinical trial · Sarcopenia · Guidelines · Recommendations · Drug registration · TreatmentSDG 3 - Good Health and Well-beingOsteoarthritismedicineHumansMuscle StrengthDrug registrationAgedScience & Technologybusiness.industryWORKING GROUPmedicine.diseaseComorbidityClinical trialTreatmentSarcopeniaPATIENT-REPORTED OUTCOMESPhysical therapyOsteoporosisGeriatrics and GerontologyPHYSICAL PERFORMANCEbusinessAging Clinical and Experimental Research
researchProduct

Necrotizing fasciitis of the face: A life-threatening condition

2009

Necrotizing fasciitis (NF) is a highly aggressive infectious process, polymicrobial in nature, involving soft tissues with a high risk of rapid spread through superficial and deep fascial planes and muscular layers. Cervical NF is quite rare, is mostly of odontogenic origin, and may be complicated by descendant mediastinitis with a very high mortality rate. Systemic conditions impairing the patient's immune competence, such as diabetes, may play a predisposing role. An effective treatment strategy includes prompt diagnosis (clinical findings, local microbiological tests, blood culture and, if deemed necessary, histopathology), broad-spectrum antibiotic therapy as early as possible which sho…

Agingmedicine.medical_specialtyAntifungal AgentsFistulaFistulaNecrosisSettore MED/28 - Malattie OdontostomatologicheMetronidazolemedicineHumansBlood cultureFasciitis NecrotizingFasciitisIntensive care medicineAgedCandidamedicine.diagnostic_testbusiness.industryMortality rateSoft tissuemedicine.diseaseMediastinitisAnti-Bacterial AgentsMetronidazoleTreatment Outcomenecrotizing fasciitis faceFaceHistopathologyFemaleGeriatrics and GerontologybusinessTomography X-Ray Computedmedicine.drug
researchProduct